eFFECTOR Therapeutics Inc

NASDAQ:EFTR   12:58:00 PM EDT
6.91
-0.44 (-5.99%)
Earnings Announcements

eFFECTOR Therapeutics Reports Third Quarter 2021 Financial Results

Published: 11/08/2021 12:40 GMT
eFFECTOR Therapeutics Inc (EFTR) - Effector Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Earnings per Share $0.42.
Revenue is expected to be $0.1 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.